January 2019 FDA Recall Drug by Heritage Pharmaceuticals, Inc.
D-0352-2019 - Lack of Assurance of Sterility

This Class II drug recall was voluntarily initiated by Heritage Pharmaceuticals, Inc. on January 2, 2019 for the product Drug. The FDA reported the reason for recall as lack of assurance of sterility. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0352-2019

Reason for Recall
Lack of Assurance of Sterility: complaints received about dried powder on the outside of bottle
Initiated
01-02-2019
Reported
01-16-2019
Quantity
5,060 units

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Heritage Pharmaceuticals, Inc.
Cidofovir Injection 375mg/5mL (75mg/mL) vial injection. 5 mL vials, Rx only, Mfd by: Emcure Pharmaceuticals Ltd., Hinjawadi, Pune, India Mfg. for : Heritage Pharmaceuticals Inc. NDC 23155-0216-31

Batch or Lot Expiration Information

Lot# : VCIA082, Exp. MAY 2020; VCIA083, VCIA084, Exp. JUNE 2020